XRHealth Acquires RealizedCare, Expanding to Largest AI-Driven Therapeutic XR Platform XRHealth, a leader in therapeutic virtual reality (VR), mixed reality (MR), and extended reality (XR) solutions, has acquired the immersive…
Galderma’s Nemluvio® (Nemolizumab) Approved for Atopic Dermatitis and Prurigo Nodularis in the UK and Switzerland Galderma has announced that the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) and…
CancerX Unveils 2025 Accelerator to Propel Oncology Innovation CancerX, a public-private partnership aimed at accelerating cancer innovation, has announced the launch of its 2025 Accelerator cohort. This year’s group includes…
Pneuma Respiratory Enhances Inhaled Therapies for Better Respiratory Health Pneuma Respiratory, a leading med-tech and pharmaceutical company, is pioneering innovative solutions in inhaled respiratory therapeutics aimed at transforming respiratory care.…
UK’s EDX Medical Develops New ‘Super Test’ for Prostate Cancer Scientists in Cambridge have created a groundbreaking new ‘super test’ for prostate cancer, aiming to transform the way the disease…
Cancer Breakthroughs: Veracyte’s Decipher Tests and GRID Tool at ASCO GU Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that new data presented at the 2025 ASCO…
OrthoNebraska Chooses Health Catalyst Ignite™ for Data-Driven Care Health Catalyst, Inc. (Nasdaq: HCAT), a leader in data and analytics technology for healthcare organizations, has announced a multi-year partnership with OrthoNebraska,…
Waystar Named Leading AI-Powered Software Platform Waystar Holding Corp. (Nasdaq: WAY), a leader in healthcare payment software, has been recognized as the industry’s top AI-powered software platform by Black Book…
Cigna Foundation Accepting 2025 Youth Mental Health Grant Applications The Cigna Group Foundation, the philanthropic branch of The Cigna Group (NYSE: CI), is stepping up efforts to address the growing…
Pfizer’s TALZENNA® and XTANDI® Combo Enhances Survival in Metastatic Castration-Resistant Prostate Cancer Pfizer Inc. (NYSE: PFE) has announced promising results from the Phase 3 TALAPRO-2 study, which tested TALZENNA® (talazoparib),…
HealthStream’s CredentialStream® Achieves HITRUST r2 Certification for Top Healthcare Data Security HealthStream (Nasdaq: HSTM), a leading healthcare technology provider for workforce solutions, announced today that its SaaS-based CredentialStream application, along…
Newleos Therapeutics Raises $93.5 Million in Oversubscribed Series A to Transform Neuropsychiatric Disorder Treatments Newleos Therapeutics, Inc., a clinical-stage neuroscience company co-founded by Longwood Fund and experienced leaders in CNS…